TKNO logo

ALPHA TEKNOVA INC

TKNONASDAQ
πŸ† #2969 by market capEarnings Nov 4 Β· PostUS Equity
$8.08β–² $0.24 (+3.00%)
Pre-market Β· at close
πŸ””
Track TKNO
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 3.0%
7dβ–² 25.8%
14dβ–² 14.0%
30dβ–Ό 9.1%
ytdβ–² 112.1%
1yβ–² 60.6%
🏦Market Cap
$434M
Small Cap
πŸ“ˆRevenue Growth (YoY)
7.3%
Slowing
πŸ“ŠGross Margin
33.9%
Moderate
πŸ’΅FCF Margin
-16.4%
Thin
βš–οΈP/S Ratio
9.9x
Elevated
Otter Score
72
Strong

Trading Snapshot

Day Range
$7.91 – $8.15
52-Week Range
$1.91 – $9.48
Volume (shares)
53,154
Avg Volume (shares)
β€”
Shares Outstanding
53.7M
Next Earnings
2026-11-04

Fundamentals Snapshot

Annual Revenue
$41M
Last Q Revenue
$12M
P/E Ratio
-25.7
P/S Ratio
9.9x
EPS (TTM)
$-0.31
Dividend Yield
0.00%
Dilution (1yr)
+0.3%
TKNO logo

ALPHA TEKNOVA INC

TKNO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$41Mβ–² +7.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
33.2%β–² +73.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$17Mβ–Ό βˆ’35.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$10Mβ–Ό βˆ’27.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
53.5Mβ–² +0.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$9Mβ–² +$17M YoY
StockOtter Β· stockotter.space

About ALPHA TEKNOVA INC

Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
72/100

Analyst Ratings

β“˜
Consensus
Buy
14 analysts
Strong Buy6
Buy6
Hold2
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.